China · Delayed Price · Currency is CNY Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 8.35 billion. The enterprise value is 7.21 billion.
| Market Cap | 8.35B |
| Enterprise Value | 7.21B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | 404.59M |
| Shares Outstanding | 404.59M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 29.19% |
| Owned by Institutions (%) | 4.64% |
| Float | 82.21M |
Valuation Ratios
The trailing PE ratio is 25.83 and the forward PE ratio is 22.20.
| PE Ratio | 25.83 |
| Forward PE | 22.20 |
| PS Ratio | 5.32 |
| PB Ratio | 3.67 |
| P/TBV Ratio | 3.82 |
| P/FCF Ratio | 47.49 |
| P/OCF Ratio | 28.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.18, with an EV/FCF ratio of 41.01.
| EV / Earnings | 22.34 |
| EV / Sales | 4.59 |
| EV / EBITDA | 20.18 |
| EV / EBIT | 21.51 |
| EV / FCF | 41.01 |
Financial Position
The company has a current ratio of 10.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.98 |
| Quick Ratio | 7.58 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 4,904.94 |
Financial Efficiency
Return on equity (ROE) is 14.68% and return on invested capital (ROIC) is 31.13%.
| Return on Equity (ROE) | 14.68% |
| Return on Assets (ROA) | 8.86% |
| Return on Invested Capital (ROIC) | 31.13% |
| Return on Capital Employed (ROCE) | 14.73% |
| Weighted Average Cost of Capital (WACC) | 5.52% |
| Revenue Per Employee | 1.54M |
| Profits Per Employee | 317,230 |
| Employee Count | 1,018 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.53 |
Taxes
In the past 12 months, SHA:603193 has paid 46.12 million in taxes.
| Income Tax | 46.12M |
| Effective Tax Rate | 12.50% |
Stock Price Statistics
The stock price has decreased by -39.87% in the last 52 weeks. The beta is 0.23, so SHA:603193's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -39.87% |
| 50-Day Moving Average | 23.89 |
| 200-Day Moving Average | 25.17 |
| Relative Strength Index (RSI) | 34.00 |
| Average Volume (20 Days) | 3,179,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.57 billion and earned 322.94 million in profits. Earnings per share was 0.80.
| Revenue | 1.57B |
| Gross Profit | 917.60M |
| Operating Income | 335.45M |
| Pretax Income | 369.06M |
| Net Income | 322.94M |
| EBITDA | 356.18M |
| EBIT | 335.45M |
| Earnings Per Share (EPS) | 0.80 |
Balance Sheet
The company has 1.14 billion in cash and 1.06 million in debt, with a net cash position of 1.14 billion or 2.82 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 1.06M |
| Net Cash | 1.14B |
| Net Cash Per Share | 2.82 |
| Equity (Book Value) | 2.27B |
| Book Value Per Share | 5.62 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was 291.89 million and capital expenditures -115.97 million, giving a free cash flow of 175.92 million.
| Operating Cash Flow | 291.89M |
| Capital Expenditures | -115.97M |
| Depreciation & Amortization | 20.73M |
| Net Borrowing | -1.52M |
| Free Cash Flow | 175.92M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 58.38%, with operating and profit margins of 21.34% and 20.55%.
| Gross Margin | 58.38% |
| Operating Margin | 21.34% |
| Pretax Margin | 23.48% |
| Profit Margin | 20.55% |
| EBITDA Margin | 22.66% |
| EBIT Margin | 21.34% |
| FCF Margin | 11.19% |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 0.46 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | 12.20% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 54.56% |
| Buyback Yield | 0.87% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 3.87% |
| FCF Yield | 2.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603193 is 32.98, which is 58.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 32.98 |
| Price Target Difference | 58.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 18.17% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603193 has an Altman Z-Score of 47.03 and a Piotroski F-Score of 6.
| Altman Z-Score | 47.03 |
| Piotroski F-Score | 6 |